NYSE:SGFY
Signify Health, Inc.
- Stock
Last Close
30.47
28/03 20:00
Market Cap
8.93B
Beta: 0.36
Volume Today
9.63M
Avg: 2.65M
PE Ratio
−41.22
PFCF: 128.17
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|
net income | -28.90M - | -28.50M 1.38% | -14.50M 49.12% | 9.90M 168.28% | -130.40M 1,417.17% | |
depreciation and amortization | 43M - | 66M 53.49% | 62.30M 5.61% | 70.70M 13.48% | 59.10M 16.41% | |
deferred income tax | 5.50M - | 800K 85.45% | -3M 475% | -30.60M 920.00% | ||
stock based compensation | 2.60M - | 4.50M 73.08% | 12.10M 168.89% | 13.20M 9.09% | 43.90M 232.58% | |
change in working capital | -2.10M - | -8.60M 309.52% | -39.40M 358.14% | -500K 98.73% | -47.20M 9,340% | |
accounts receivables | -8M - | -37.80M 372.50% | -102.50M 171.16% | 53.40M 152.10% | -37.70M 170.60% | |
inventory | -40.50M - | 10.50M 125.93% | ||||
accounts payables | 40.50M - | -10.50M 125.93% | 27.90K 100.27% | |||
other working capital | 5.90M - | 29.20M 394.92% | 63.10M 116.10% | -53.90M 185.42% | -9.53M 82.32% | |
other non cash items | 21M - | 2.80M 86.67% | 22.20M 692.86% | 39.60M 78.38% | 203.20M 413.13% | |
net cash provided by operating activities | 35.60M - | 41.70M 17.13% | 43.50M 4.32% | 129.90M 198.62% | 98M 24.56% | |
investments in property plant and equipment | -13.10M - | -25.50M 94.66% | -34.10M 33.73% | -28.60M 16.13% | -28.30M 1.05% | |
acquisitions net | 107.20M - | -14.70M 113.71% | -400K 97.28% | -190.50M 47,525% | ||
purchases of investments | -1M - | -5M 400% | -300K 94% | |||
sales maturities of investments | 34.10M - | 28.60M 16.13% | 28.30M 1.05% | |||
other investing activites | 1.20M - | -34.10M 2,941.67% | -28.60M 16.13% | -28.30M 1.05% | ||
net cash used for investing activites | -13.10M - | 82.90M 732.82% | -49.80M 160.07% | -34M 31.73% | -219.10M 544.41% | |
debt repayment | -2M - | -27.80M 1,290% | -95M 241.73% | -413.90M 335.68% | -4M 99.03% | |
common stock issued | 45.70M - | 235.50M 415.32% | 604.50M 156.69% | 11.70K 100.00% | ||
common stock repurchased | -4.10M - | -3.10M 24.39% | -56.90M 1,735.48% | |||
dividends paid | -18.30M - | -22.50M 22.95% | -8.20M 63.56% | |||
other financing activites | 2.50M - | -87.10M 3,584.00% | -42.30M 51.44% | 320.70M 858.16% | 5.19M 98.38% | |
net cash used provided by financing activities | -21.90M - | -94.80M 332.88% | 33.10M 134.92% | 511.30M 1,444.71% | 1.20M 99.77% | |
effect of forex changes on cash | -69.10M - | |||||
net change in cash | 600K - | 29.80M 4,866.67% | 26.80M 10.07% | 607.20M 2,165.67% | -189M 131.13% | |
cash at beginning of period | 19.80M - | 20.40M 3.03% | 50.20M 146.08% | 77M 53.39% | 684.20M 788.57% | |
cash at end of period | 20.40M - | 50.20M 146.08% | 77M 53.39% | 684.20M 788.57% | 495.20M 27.62% | |
operating cash flow | 35.60M - | 41.70M 17.13% | 43.50M 4.32% | 129.90M 198.62% | 98M 24.56% | |
capital expenditure | -13.10M - | -25.50M 94.66% | -34.10M 33.73% | -28.60M 16.13% | -28.30M 1.05% | |
free cash flow | 22.50M - | 16.20M 28.00% | 9.40M 41.98% | 101.30M 977.66% | 69.70M 31.19% |
All numbers in USD (except ratios and percentages)